Clinical Trial: The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.

U.S., Oct. 9 -- ClinicalTrials.gov registry received information related to the study (NCT07212062) titled 'The Purpose of This Study is to Evaluate the Safety and Tolerability of X/T+X-EC in Participants With Alzheimer's Disease Who Are Currently Treated With Lecanemab.' on Sept. 22.

Brief Summary: The goal of the trial is to see if the Safety and Tolerability of X/T+X/T-EC combined with currently treated Lecanemab participants with Alzheimer's Disease compared with placebo. This is a 32 week study (4 weeks of screening,24 weeks of treatment and 4 weeks of safety follow up)

Study Start Date: Dec. 01

Study Type: INTERVENTIONAL

Condition: Alzheimers Disease

Intervention: DRUG: X/T + X-EC

Xanomeline and Trospium Chloride Capsules

DRU...